1141 related articles for article (PubMed ID: 10432323)
41. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
[TBL] [Abstract][Full Text] [Related]
42. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
Welles SL; Pitt J; Colgrove R; McIntosh K; Chung PH; Colson A; Lockman S; Fowler MG; Hanson C; Landesman S; Moye J; Rich KC; Zorrilla C; Japour AJ
AIDS; 2000 Feb; 14(3):263-71. PubMed ID: 10716502
[TBL] [Abstract][Full Text] [Related]
43. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
[TBL] [Abstract][Full Text] [Related]
44. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
[TBL] [Abstract][Full Text] [Related]
45. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
[TBL] [Abstract][Full Text] [Related]
46. HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.
Alcântara KC; Lins JB; Albuquerque M; Aires LM; Cardoso LP; Minuzzi AL; Stefani MM
J Clin Virol; 2012 May; 54(1):15-20. PubMed ID: 22317908
[TBL] [Abstract][Full Text] [Related]
47. Maternal HIV-1 DNA load and mother-to-child transmission.
Arvold ND; Ngo-Giang-Huong N; McIntosh K; Suraseranivong V; Warachit B; Piyaworawong S; Changchit T; Lallemant M; Jourdain G;
AIDS Patient Care STDS; 2007 Sep; 21(9):638-43. PubMed ID: 17919090
[TBL] [Abstract][Full Text] [Related]
48. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.
Avettand-Fenoel V; Blanche S; Le Chenadec J; Scott-Algara D; Dollfus C; Viard JP; Bouallag N; Benmebarek Y; Rivière Y; Warszawski J; Rouzioux C; Buseyne F
J Infect Dis; 2012 May; 205(10):1520-8. PubMed ID: 22427678
[TBL] [Abstract][Full Text] [Related]
49. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
Venkatesh KK; Lurie MN; Triche EW; De Bruyn G; Harwell JI; McGarvey ST; Gray GE
Trop Med Int Health; 2010 Nov; 15(11):1364-74. PubMed ID: 20955499
[TBL] [Abstract][Full Text] [Related]
50. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
51. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
[TBL] [Abstract][Full Text] [Related]
52. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
Short CE; Douglas M; Smith JH; Taylor GP
HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
[TBL] [Abstract][Full Text] [Related]
53. [Vertical transmission of HIV infection: risk factors and prevention strategies].
Grignaffini A; Cavatorta E; Verrotti C; Soncini E; Pelicelli A; Fieni S; Magnani G; Benaglia G
Acta Biomed Ateneo Parmense; 2000; 71(5):167-78. PubMed ID: 11450119
[TBL] [Abstract][Full Text] [Related]
54. Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy.
Cotter AM; Brookfield KF; Duthely LM; Gonzalez Quintero VH; Potter JE; O'Sullivan MJ
Am J Obstet Gynecol; 2012 Dec; 207(6):482.e1-5. PubMed ID: 23103331
[TBL] [Abstract][Full Text] [Related]
55. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
Lallemant M; Jourdain G; Le Coeur S; Mary JY; Ngo-Giang-Huong N; Koetsawang S; Kanshana S; McIntosh K; Thaineua V;
N Engl J Med; 2004 Jul; 351(3):217-28. PubMed ID: 15247338
[TBL] [Abstract][Full Text] [Related]
56. A controlled trial of zidovudine in primary human immunodeficiency virus infection.
Kinloch-De Loës S; Hirschel BJ; Hoen B; Cooper DA; Tindall B; Carr A; Saurat JH; Clumeck N; Lazzarin A; Mathiesen L
N Engl J Med; 1995 Aug; 333(7):408-13. PubMed ID: 7616989
[TBL] [Abstract][Full Text] [Related]
57. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission Study.
Hershow RC; Riester KA; Lew J; Quinn TC; Mofenson LM; Davenny K; Landesman S; Cotton D; Hanson IC; Hillyer GV; Tang HB; Thomas DL
J Infect Dis; 1997 Aug; 176(2):414-20. PubMed ID: 9237706
[TBL] [Abstract][Full Text] [Related]
58. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group.
Rich KC; Fowler MG; Mofenson LM; Abboud R; Pitt J; Diaz C; Hanson IC; Cooper E; Mendez H
Pediatrics; 2000 Jan; 105(1):e8. PubMed ID: 10617745
[TBL] [Abstract][Full Text] [Related]
59. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group.
Thea DM; Steketee RW; Pliner V; Bornschlegel K; Brown T; Orloff S; Matheson PB; Abrams EJ; Bamji M; Lambert G; Schoenbaum EA; Thomas PA; Heagarty M; Kalish ML
AIDS; 1997 Mar; 11(4):437-44. PubMed ID: 9084790
[TBL] [Abstract][Full Text] [Related]
60. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
